Structural Heart Devices Market by Product Type (Heart Valve Devices, Occluders and Delivery Systems, Annuloplasty Rings, and Accessories), by Indication (Atrial Septal Defect (ASD), Patent Foramen Ovale (PFO), Ventricular Septal Defect (VSD), and Aortic Valve Stenosis), and by End-User (Hospitals, Ambulatory Surgical Centers, and others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019—2025

Description

The report covers a forecast and an analysis of the structural heart devices market on a global and regional level. The study provides historical data from 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based revenue (USD Million). The study includes the drivers and restraints of the Structural Heart Devices Market along with the impact they have on the demand over the forecast time period. Additionally, the report includes the study of opportunities available in the Structural Heart Devices Market on a global level.

In order to give the users of this report a comprehensive view of the Structural Heart Devices Market, we have included a competitive landscape and an analysis of Porter’s Five Forces model of the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments in the market, including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the Structural Heart Devices Market by segmenting the market based on product type, indication, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025.

By product type, the structural heart devices market includes heart valve devices, occluders, and delivery systems, annuloplasty rings, and accessories. By indication, the structural heart devices market is segmented into atrial septal defect (ASD), patent foramen ovale (PFO), ventricular septal defect (VSD), and aortic valve stenosis. By end-user, the structural heart devices market is segmented into hospitals, ambulatory surgical centers, and others.

The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further segmentation into major countries, including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some major market players of the global structural heart devices include Abbott Laboratories, Medtronic Plc., Endologix Inc., LivaNova Plc., Boston Scientific Corporation, CryoLife Inc., Cook Group Incorporated, Edwards Lifesciences Corporation, and W. L. Gore & Associates, Inc., among others.

This report segments the global structural heart devices market into:

Global Structural Heart Devices Market: Product Type Analysis

• Heart Valve Devices
• Occluders and Delivery Systems
• Annuloplasty Rings
• Accessories

Global Structural Heart Devices Market: Indication Analysis

• Atrial Septal Defect (ASD)
• Patent Foramen Ovale (PFO)
• Ventricular Septal Defect (VSD)
• Aortic Valve Stenosis

Global Structural Heart Devices Market: End-User Analysis

• Hospitals
• Ambulatory Surgical Centers

• Others

Global Structural Heart Devices Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

Table Of Content

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global Structural Heart Devices Market, 2016 - 2025 (USD Million)
  • 2.2. Global Structural Heart Devices Market: Snapshot
•  
• Chapter 3. Structural Heart Devices Market - Industry Dynamics
  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Global Structural Heart Devices Market drivers: Impact analysis
    • 3.2.2. Increased prevalence of congenital heart defects
    • 3.2.3. Increase in minimally invasive procedures
    • 3.2.4. Increase in research and development activities led to the innovation of new products
  • 3.3. Market Restraints
    • 3.3.1. The high cost of structural heart devices
    • 3.3.2. The stringent regulatory approval process
  • 3.4. Opportunities
    • 3.4.1. Technological advancement and development
  • 3.5. Porter's Five Forces analysis
    • 3.5.1. Bargaining power of suppliers
    • 3.5.2. Bargaining power of buyers
    • 3.5.3. The threat from new entrants
    • 3.5.4. The threat from new substitutes
    • 3.5.5. Degree of competition
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by Product Type
    • 3.6.2. Market attractiveness analysis, by Indication
    • 3.6.3. Market attractiveness analysis, by End-User
    • 3.6.4. Market attractiveness analysis, by Regional Segment
•  
• Chapter 4. Global Structural Heart Devices Market - Competitive Landscape
  • 4.1. Company Market Share Analysis
    • 4.1.1. Global Structural Heart Devices Market: company market share, 2015
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions & Mergers
    • 4.2.2. New Product Type Launch
    • 4.2.3. Agreements, Partnerships, Collaborations, and Joint Ventures
    • 4.2.4. Research and Development and Regional Expansion
•  
• Chapter 5. Global Structural Heart Devices Market - Product Type Analysis
  • 5.1. Global Structural Heart Devices Market: Product Type overview
    • 5.1.1. Global Structural Heart Devices Market revenue share, by Product Type, 2016 and 2025(USD Million)
  • 5.2. Heart Valve Devices
    • 5.2.1. Global Heart Valve Devices market, 2016 - 2025(USD Million)
  • 5.3. Occluders and Delivery Systems
    • 5.3.1. Global Occluders and Delivery Systems market, 2016 - 2025(USD Million)
  • 5.4. Annuloplasty Rings
    • 5.4.1. Global Annuloplasty Rings market, 2016 - 2025(USD Million)
  • 5.5. Accessories
    • 5.5.1. Global Accessories market, 2016 - 2025(USD Million)
•  
• Chapter 6. Global Structural Heart Devices Market - Indication Analysis
  • 6.1. Global Structural Heart Devices Market: Indication overview
    • 6.1.1. Global Structural Heart Devices Market revenue share, by indication, 2016 and 2025(USD Million)
  • 6.2. Atrial Septal Defect (ASD)
    • 6.2.1. Global Atrial Septal Defect (ASD)market, 2016 - 2025(USD Million)
  • 6.3. Patent Foramen Ovale (PFO)
    • 6.3.1. Global Patent Foramen Ovale (PFO)market, 2016 - 2025(USD Million)
  • 6.4. Ventricular Septal Defect (VSD)
    • 6.4.1. Global Ventricular Septal Defect (VSD)market, 2016 - 2025(USD Million)
  • 6.5. Aortic Valve Stenosis
    • 6.5.1. Global Aortic Valve Stenosis market, 2016 - 2025(USD Million)
•  
• Chapter 7. Global Structural Heart Devices Market - End-User Analysis
  • 7.1. Global Structural Heart Devices Market: End-User overview
    • 7.1.1. Global Structural Heart Devices Market revenue share, by End-User, 2016 and 2025(USD Million)
  • 7.2. Hospitals
    • 7.2.1. Global Structural Heart Devices Market for Hospitals, 2016 - 2025(USD Million)
  • 7.3. Ambulatory Surgical Centers
    • 7.3.1. Global Structural Heart Devices Market for Ambulatory Surgical Centers, 2016 - 2025(USD Million)
  • 7.4. Others
    • 7.4.1. Global Structural Heart Devices Market for Others, 2016 - 2025(USD Million)
•  
• Chapter 8. Global Structural Heart Devices Market - Regional Analysis
  • 8.1. Global Structural Heart Devices Market: Regional overview
    • 8.1.1. Global Structural Heart Devices Market revenue share, by Region, 2016 and 2025
  • 8.2. North America
    • 8.2.1. North America Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
    • 8.2.2. North America Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
    • 8.2.3. North America Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
    • 8.2.4. The U.S.
      • 8.2.4.1. The U.S. Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
      • 8.2.4.2. The U.S. Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
      • 8.2.4.3. The U.S. Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
    • 8.2.5. Rest of North America
      • 8.2.5.1. Rest of North America Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
      • 8.2.5.2. Rest of North America Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
      • 8.2.5.3. Rest of North America Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
    • 8.3.2. Europe Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
    • 8.3.3. Europe Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
    • 8.3.4. Germany
      • 8.3.4.1. Germany Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
      • 8.3.4.2. Germany Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
      • 8.3.4.3. Germany Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
    • 8.3.5. UK
      • 8.3.5.1. UK Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
      • 8.3.5.2. UK Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
      • 8.3.5.3. UK Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
    • 8.3.6. France
      • 8.3.6.1. France Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
      • 8.3.6.2. France Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
      • 8.3.6.3. France Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
    • 8.3.7. Rest of Europe
      • 8.3.7.1. Rest of Europe Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
      • 8.3.7.2. Rest of Europe Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
      • 8.3.7.3. Rest of Europe Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
    • 8.4.2. Asia Pacific Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
    • 8.4.3. Asia Pacific Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
    • 8.4.4. China
      • 8.4.4.1. China Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
      • 8.4.4.2. China Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
      • 8.4.4.3. China Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
    • 8.4.5. Japan
      • 8.4.5.1. Japan Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
      • 8.4.5.2. Japan Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
      • 8.4.5.3. Japan Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
    • 8.4.6. India
      • 8.4.6.1. India Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
      • 8.4.6.2. India Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
      • 8.4.6.3. India Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
    • 8.4.7. Rest of Asia Pacific
      • 8.4.7.1. Rest of Asia Pacific Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
      • 8.4.7.2. Rest of Asia Pacific Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
      • 8.4.7.3. Rest of Asia Pacific Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
    • 8.5.2. Latin America Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
    • 8.5.3. Latin America Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
    • 8.5.4. Brazil
      • 8.5.4.1. Brazil Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
      • 8.5.4.2. Brazil Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
      • 8.5.4.3. Brazil Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
    • 8.5.5. Rest of Latin America
      • 8.5.5.1. Rest of Latin America Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
      • 8.5.5.2. Rest of Latin America Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
      • 8.5.5.3. Rest of Latin America Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
  • 8.6. The Middle East and Africa
    • 8.6.1. The Middle East and Africa Structural Heart Devices Market Revenue, by Product Type, 2016 - 2025(USD Million)
    • 8.6.2. The Middle East and Africa Structural Heart Devices Market revenue, by Indication, 2016 - 2025(USD Million)
    • 8.6.3. The Middle East and Africa Structural Heart Devices Market revenue, by End-User, 2016 - 2025(USD Million)
•  
• Chapter 9. Company Profile
  • 9.1. Abbott Laboratories
    • 9.1.1. Overview
    • 9.1.2. Financials
    • 9.1.3. Indication portfolio
    • 9.1.4. Business strategy
    • 9.1.5. Recent developments
  • 9.2. Medtronic Plc.
    • 9.2.1. Overview
    • 9.2.2. Financials
    • 9.2.3. Indication portfolio
    • 9.2.4. Business strategy
    • 9.2.5. Recent developments
  • 9.3. Endologix Inc.
    • 9.3.1. Overview
    • 9.3.2. Financials
    • 9.3.3. Indication portfolio
    • 9.3.4. Business strategy
    • 9.3.5. Recent developments
  • 9.4. LivaNova Plc.
    • 9.4.1. Overview
    • 9.4.2. Financials
    • 9.4.3. Indication portfolio
    • 9.4.4. Business strategy
    • 9.4.5. Recent developments
  • 9.5. Boston Scientific Corporation
    • 9.5.1. Overview
    • 9.5.2. Financials
    • 9.5.3. Indication portfolio
    • 9.5.4. Business strategy
    • 9.5.5. Recent developments
  • 9.6. CryoLife Inc.
    • 9.6.1. Overview
    • 9.6.2. Financials
    • 9.6.3. Indication portfolio
    • 9.6.4. Business strategy
    • 9.6.5. Recent developments
  • 9.7. Cook Group Incorporated
    • 9.7.1. Overview
    • 9.7.2. Financials
    • 9.7.3. Indication portfolio
    • 9.7.4. Business strategy
    • 9.7.5. Recent developments
  • 9.8. Edwards Lifesciences Corporation
    • 9.8.1. Overview
    • 9.8.2. Financials
    • 9.8.3. Indication portfolio
    • 9.8.4. Business strategy
    • 9.8.5. Recent developments
  • 9.9. W. L. Gore & Associates, Inc.
    • 9.9.1. Overview
    • 9.9.2. Financials
    • 9.9.3. Indication portfolio
    • 9.9.4. Business strategy
    • 9.9.5. Recent developments

Methodology

Free Analysis

Structural heart devices are used to maintain the normal structure of a human heart. Due to the various congenital defects and cardiovascular infections, heart muscles lose their shape. This, in turn, affects the normal functioning of the heart. Common heart structural diseases include atrial septal defects, patient foramen ovale, Paravalvular leak, etc. These devices can be placed through minimally invasive procedures, whereas a few cases need open heart surgery. Minimally invasive surgeries have reduced the risk and decreased the recovery time.

One of the major factors likely to drive the structural heart devices market globally in the future is the constant increase in the prevalence of congenital heart defects. As per the Centers for Disease Control and Prevention 2018 report, there were around 40,000 infants diagnosed with congenital heart defects in the U.S. Moreover, there is a constant increase in the demand of minimally invasive surgeries coupled with an increased recovery rate. Furthermore, substantial increase related to technological advancements and research and development activities has resulted in the introduction of innovative products, thereby promoting the structural heart devices market growth in the future. However, the high cost of these devices and the enforcement of stringent legislation governing the approval of new devices might hamper the structural heart devices market over the estimated time span.

The global structural heart devices market is classified on the basis of product type, indication, and end-user. By product type, the structural heart devices market includes heart valve devices, occluders, and delivery systems, annuloplasty rings, and accessories. Heart valve devices are expected to dominate the structural heart devices market in the upcoming years. By indication, the structural heart devices market is segmented into atrial septal defect (ASD), patent foramen ovale (PFO), ventricular septal defect (VSD), and aortic valve stenosis. By end-user, the structural heart devices market is segmented into hospitals, ambulatory surgical centers, and others.

By region, the global structural heart devices market includes North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to lead the structural heart devices market globally over the forecast time period, followed by Europe. The Asia Pacific region is projected to be the fastest growing region over the estimated timeframe, owing to the significant contributions made by developing economies, such as India and China. The Latin American and the Middle Eastern and African markets are anticipated to grow moderately in the future.

Some major market players of the global structural heart devices include Abbott Laboratories, Medtronic Plc., Endologix Inc., LivaNova Plc., Boston Scientific Corporation, CryoLife Inc., Cook Group Incorporated, Edwards Lifesciences Corporation, and W. L. Gore & Associates, Inc., among others.